Abstract
In 2006, the Japan Pancreas Society revised the diagnostic criteria for autoimmune pancreatitis (AIP) so as to more clearly define its morphological, pathological, and immunological features, as follows: (1) diffuse or segmental narrowing of the main pancreatic duct with an irregular wall and diffuse or localized enlargement of the pancreas recognized by imaging studies; (2) high serum gamma globulin, IgG, or IgG4 levels, or the presence of autoantibodies; and (3) marked interlobular fibrosis and prominent infiltration of lymphocytes and plasma cells in the periductal area, occasionally with lymphoid follicles in the pancreas. Establishing a diagnosis of AIP has become easier with knowledge of its immunological abnormalities, including serum IgG4 levels. However, the localized form of AIP sometimes mimics pancreatic cancer. The rate of focal mass formation in patients with AIP is reportedly 24%–43%; however, there have been few reports on the histological findings of localized AIP, in contrast to mass-forming pancreatitis (MFP). Our review of patients who had undergone resection due to a preoperative diagnosis of MFP with possible cancer revealed 72% to be patients with localized AIP. For the discrimination of these conditions, it is important to recognize the characteristic ultrasonographic findings of AIP, i.e., (1) diffuse or localized enlargement and hypoechogenicity of the pancreas; (2) rarity of calcification, cystic lesions, and peripancreatic fluid collection; (3) thickened layer structure of the bile duct wall; (4) iso/hypervascularity in the swollen portion of the pancreas; (5) attenuation of pancreatic swelling and bile duct wall thickening after steroid therapy; and (6) multiple hypoechoic masses in various organs, including the pancreas. Contrast-enhanced endoscopic ultrasonography is potentially a useful tool in the differential diagnosis and for assessment of the efficacy of steroid therapy by enabling evaluation of the vascularity of the lesions. Along with the presence of IgG4-positive plasma cells, verification of obliterative phlebitis is highly specific for the histological diagnosis of AIP.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis 1961;6:689–698.
Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis — does it exit? Pancreas 2003;27:1–13.
Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010–1016.
Zamboni G, Lüttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552–563.
Klöppel G, Lüttges J, Löhr M, et al. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 2003;27:14–19.
Kim KP, Kim MH, Song MH, et al. Autoimmune CP. Am J Gastroenterol 2004;99:1605–1616.
Toki F, Kozu T, Oi I, et al. An unusual type of CP showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP — a report of four cases. Endoscopy 1992;24:640.
Yoshida K, Toki F, Takeuchi T, et al. CP caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561–1568.
Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387–395.
Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 2001;48:625–630.
Kojima E, Kimura K, Noda Y, et al. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003;38:603–607.
Uehara T, Hamano H, Kawa S, et al. The distinct clinicopathological entity “autoimmune pancreatitis-associated sclerosing cholangitis”. Pathol Int 2005;55:405–411
Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732–738.
Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003;52:683–687.
Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 2005;31:232–237.
Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982–984.
Wakabayashi T, Kawaura Y, Satomura Y, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumorforming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003;98:2679–2687.
Kobayashi G, Fujita N, Noda Y, et al. Lymphoplasmacytic sclerosing pancreatitis forming a localized mass: a variant form of autoimmune pancreatitis. J Gastroenterol 2007;42:650–656.
Etemad B, Whitcomb DC. CP diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682–707.
Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626–631.
Neff CC, Simeone JF, Wittenberg J, et al. Inflammatory pancreatic masses. Radiology 1984;150:35–38.
Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct-destructive CP. Gut 1997;41:263–268.
Notohara K, Burgart LJ, Yadav D, et al. Idiopathic duct-centric chronic CP with periductal lymphoplasmacytic infiltration: clinicopathological features of 35 cases. Am J Surg Pathol 2003;27:1119–1127.
Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and Th1/Th2-cellular immune response. Gastroenterology 2000;118:573–581.
Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med 2007;356:1586–1587.
Weber SM, Cubukcu-Dimopulo O, Palesty JA, et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003;7:129–137; discussion 137-9.
Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreatoduodenectomy (Whipple resections) in patients without malignancy: are they all “CP”? Am J Surg Pathol 2003;27:110–120
Nakazawa T, Ohara H, Sano H, et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc 2007;65:99–108.
Farrell JJ, Garber J, Sahani D, et al. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004;60:927–936.
Takase M, Suda K. Histopathological study on mechanism and background of tumor-forming pancreatitis. Pathol Int 2001;51:349–354.
Medical ultrasonographic diagnostic criteria committee. Diagnostic criteria for pancreatic cancer. Jpn J Med Ultrasonics 1992;19:553–557.
Horiguchi Y, Kitano T, Ohsuki M, et al. Ultrasonographic differentiation between inflammatory mass and pancreatic cancer. Jpn J Med Ultrasonics 1985;12:310–320 (in Japanese with English abstract).
Lammer J, Herlinger H, Zalaudek G, et al. Pseudotumorous pancreatitis. Gastrointest Radiol 1985;10:59–67.
Rosch T, Lorenz R, Braig C, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991;37:347–352.
van Gulik TM, Reeders JWAJ, Bosma A, et al. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 1997;46:417–423.
Baron PL, Aabakken LE, Cole DJ, et al. Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol 1997;4:639–643.
Glansbrenner B, Schwarz M, Paul S, et al. Prospective comparison of endoscopic ultrasound and endoscopic retrograde cholangiography in the prospective assessment of masses in the pancreatic head. Dig Surg 2000;17:468–474.
Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentogenol 1998;170:1323–1327.
Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonographyguided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997;112:1087–1095.
Nishimura T, Masoka T, Suzuki H, et al. Autoimmune pancreatitis with pseudocysts. J Gastroenterol 2004;39:1005–1010.
Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004;99:932–937.
Hyodo N, Hyodo, T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol 2003;38:1155–1161.
Hyodo T, Hyodo N, Yamanaka T, et al. Contrast-enhancement intraductal ultrasonography for thickened bile duct wall. J Gastroenterol 2001;36:557–559.
Koito K, Namieno T, Nagakawa T, et al. Inflammatory pancreatic masses: differentiation from ductal carcinomas with ce sonography using carbon dioxide microbubbles. Am J Roentgenol 1997;169:1263–1267.
Oshikawa O, Tanaka S, Ioka T, et al. Dynamic sonography of pancreatic tumors: comparison with dynamic CT. Am J Roentgenol 2002;178:1133–1137.
Ozawa Y, Numata K, Tanaka K, et al. Contrast-enhanced sonography of small pancreatic mass lesions. J Ultrasound Med 2002;21:983–991.
Rickes S, Unkrodt K, Neye H, et al. Differentiation of pancreatic tumors by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol 2002;37:1313–1320.
Kitano M, Kudo M, Maekawa K, et al. Dynamic imaging of pancreatic diseases by ce coded phase-inversion harmonic ultrasonography. Gut 2004;53:854–859.
Sofuni A, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 2005;40:518–525.
Numata K, Ozawa Y, Kobayashi N, et al. Ce sonography of autoimmune pancreatitis: comparison with pathologic findings. J Ultrasound Med 2004;23:199–206.
Okaniwa S, Oyama T, Takamatsu M, et al. A case of nonalcoholic pancreatitis treated with steroid followed up using intraductal ultrasonography and endoscopic retrograde pancreatography. Dig Endosc 1999;11:353–357.
Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002;359:1403–1404.
Uchida K, Okazaki K, Asada M, et al. Case of CP involving an autoimmune mechanism that extended to retroperitoneal fibrosis. Pancreas 2003;26:92–94.
Kamisawa T, Nakajima H, Egawa N, et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2005;6:132–137.
Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005;36:710–717.
Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis. Do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004;28:1193–1203.
Kanno A, Satoh K, Masamune A, et al. Autoimmune pancreatitis with hepatic inflammatory pseudotumor. Pancreas 2005;31:420–423.
Gumbs AA, Kim J, Kiehara E, et al. Autoimmune pancreatitis presenting as simultaneous masses in the pancreatic head and gallbladder. JOP 2005;6:455–459.
Yoshimura Y, Takeda S, Ieki Y, et al. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 2006;45:897–901.
Deheragoda MG, Church NI, Rodriguez-Justo M, et al. The use of immunoglobulin G4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol 2007;5:1229–1234.
Ohana M, Okazaki K, Hajiro K, et al. Multiple pancreatic masses associated with autoimmunity. Am J Gastroenterol 1998;93:99–102.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kobayashi, G., Fujita, N., Noda, Y. et al. Autoimmune pancreatitis: with special reference to a localized variant. J Med Ultrasonics 35, 41–50 (2008). https://doi.org/10.1007/s10396-008-0177-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10396-008-0177-z